Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense Type sort iconYearAgencyPenalty Amount
ExecuPharm, Inc.Parexel InternationalFamily and Medical Leave Act2017WHD$5,900
Pfizer H.C.P. CorporationPfizerForeign Corrupt Practices Act2012DOJ_CRIMINAL$15,000,000
Johnson & JohnsonJohnson & JohnsonForeign Corrupt Practices Act2011DOJ_CRIMINAL$21,400,000
Novartis AGNovartisForeign Corrupt Practices Act2016SEC$25,000,000
SciClone PharmaceuticalsSciClone PharmaceuticalsForeign Corrupt Practices Act2016SEC$12,000,000
Bristol-Myers SquibbBristol-Myers SquibbForeign Corrupt Practices Act2015SEC$14,000,000
Eli Lilly and CompanyEli LillyForeign Corrupt Practices Act2012SEC$29,398,734
Pfizer Inc.PfizerForeign Corrupt Practices Act2012SEC$26,339,944
Wyeth LLCPfizerForeign Corrupt Practices Act2012SEC$18,876,624
Johnson & JohnsonJohnson & JohnsonForeign Corrupt Practices Act2011SEC$48,600,000
Micrus CorporationJohnson & JohnsonForeign Corrupt Practices Act2005DOJ_CRIMINAL$450,000
Novo Nordisk A/SNovo Holdings A/SForeign Corrupt Practices Act2009SEC$9,030,149
Schering-Plough CorporationMerckForeign Corrupt Practices Act2004SEC$500,000
Teva Pharmaceutical Industries LtdTeva Pharmaceutical IndustriesForeign Corrupt Practices Act2016DOJ_CRIMINAL$283,177,348
Teva Pharmaceutical Industries LimitedTeva Pharmaceutical IndustriesForeign Corrupt Practices Act2016SEC$236,000,000
SanofiSanofiForeign Corrupt Practices Act2018SEC$25,200,000
Novartis Hellas S.A.C.I. et al.NovartisForeign Corrupt Practices Act2020DOJ_CRIMINAL$233,000,000
Alexion Pharmaceuticals Inc.AstraZenecaForeign Corrupt Practices Act2020SEC$21,000,000
Novartis AGNovartisForeign Corrupt Practices Act2020SEC$112,800,000
Bristol-Myers SquibbBristol-Myers Squibbfraud2005USAO$300,000,000
ICN Pharmaceuticals, Inc.Bausch Healthfraud2001USAO$5,600,000
Dey, Inc.Viatrisfraud2004AR-AG$600,000
Purdue Pharma LPPurdue Pharmafraud2020DOJ_CIVIL$8,344,000,000
Glenmark Pharmaceuticals, Inc.Glenmark PharmaceuticalsHHS civil monetary penalties2015HHSOIG$2,887,300
Sandoz, Inc.Sandoz GroupHHS civil monetary penalties2015HHSOIG$12,640,000
Sandoz, Inc.Sandoz GroupHHS civil monetary penalties2011HHSOIG$230,000
Advanced Neuromodulation Systems, Inc.Abbott LaboratoriesHHS civil monetary penalties2007HHSOIG$2,950,000
Valeant Pharmaceuticals, Inc.Bausch Healthinsurance violation2018CA-INS$1,875,000
Johnson & Johnson, Inc.Johnson & Johnsoninsurance violation2020NC-INS$150,000
Schering-Plough CorporationMerckinvestor protection violation2003SEC$1,000,000
Allergan Inc.AbbVieinvestor protection violation2017SEC$15,000,000
Aegerion PharmaceuticalsAmryt Pharmainvestor protection violation2017SEC$4,100,000
Cytrx CorporationCytRxinvestor protection violation2017SEC$75,000
Clovis Oncology Inc.Clovis Oncologyinvestor protection violation2018SEC$20,000,000
Valeant Pharmaceuticals International, Inc.Bausch Healthinvestor protection violation2017MULTI-AG$145,000,000
Mylan N.V.Viatrisinvestor protection violation2019SEC$30,000,000
Amyris, Inc.Amyrisinvestor protection violation2021SEC$300,000
St. Jude Medical Inc.Abbott Laboratorieskickbacks and bribery2011DOJ_CIVIL$16,000,000
Kos PharmaceuticalsAbbViekickbacks and bribery2010FDA$41,500,000
Novartis PharmaceuticalsNovartiskickbacks and bribery2015USAO$390,000,000
Schering-Plough CorporationMerckkickbacks and bribery2004DOJ_CIVIL$345,000,000
Novo Nordisk A/SNovo Holdings A/Skickbacks and bribery2009DOJ_CRIMINAL$9,000,000
AstraZeneca PLCAstraZenecakickbacks and bribery2016SEC$5,522,000
GlaxoSmithKline plcGlaxoSmithKlinekickbacks and bribery2016SEC$20,000,000
Salix Pharmaceuticals Inc.Bausch Healthkickbacks and bribery2016USAO$54,000,000
Biovail Pharmaceuticals Inc.Bausch Healthkickbacks and bribery2009USAO$24,647,876
Pharmacia & Upjohn Company Inc.Pfizerkickbacks and bribery2007USAO$19,700,000
Pharmacia & Upjohn Company LLCPfizerkickbacks and bribery2007USAO$15,000,000
AbbVie Inc.AbbViekickbacks and bribery2018MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,800,000
Alere Inc.Abbott Laboratorieskickbacks and bribery2017MS-AG$2,000,000
GlaxoSmithKline, LLCGlaxoSmithKlinekickbacks and bribery2014MULTI-AG$105,000,000
Kos PharmaceuticalsAbbViekickbacks and bribery2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432
Mallinckrodt ARD LLCMallinckrodtkickbacks and bribery2019DOJ_CIVIL$15,400,000
Novartis Pharmaceuticals CorporationNovartiskickbacks and bribery2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754
Pfizer, Inc.Pfizerkickbacks and bribery2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170
Salix Pharmaceuticals Inc.Bausch Healthkickbacks and bribery2016MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000
Sanofi US Services, Inc.Sanofikickbacks and bribery2013MULTI-AG$617,000
Schering-Plough CorporationMerckkickbacks and bribery2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482
TAP Pharmaceutical Products, Inc.Takeda Pharmaceuticalkickbacks and bribery2006KY-AG$600,000
TAP Pharmaceutical Products, Inc.Takeda Pharmaceuticalkickbacks and bribery2006WI-AG$798,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industrieskickbacks and bribery2014IL-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000
Bristol-Myers SquibbBristol-Myers Squibbkickbacks and bribery2016CA-INS$30,000,000
Novartis Pharmaceuticals CorporationNovartiskickbacks and bribery2020CA-AG$11,800,000
Novartis Pharmaceuticals Corp.Novartiskickbacks and bribery2020MULTI-AG$103,000,000
Pacira Pharmaceuticals, Inc.Pacira BioScienceskickbacks and bribery2020MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000
Parexel International, LLCParexel Internationallabor relations violation2012NLRB$253,000
Amgen, Inc.Amgenlabor relations violation2011NLRB$40,000
Merck and Company, Inc.Mercklabor relations violation2009NLRB$10,710
Merck & Co., Inc.Mercklabor relations violation2008NLRB$100,000
Schering-PloughMercklabor relations violation2007NLRB$8,200
Boehringer Ingelheim Pharmaceutical, Inc.Boehringer Ingelheimlabor relations violation2004NLRB$50,000
Advanced Medical OpticsAbbott Laboratorieslabor relations violation2004NLRB$16,800
Therasense, Inc.Abbott Laboratorieslabor relations violation2003NLRB$236,827
Actavis Kadian, LLCAbbVieMedicare Coverage Gap Discount Program violation2013CMS$116,703
Intermune, Inc.RocheMedicare Coverage Gap Discount Program violation2013CMS$5,641
Intermune, Inc.RocheMedicare Coverage Gap Discount Program violation2013CMS$16,215
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2015CMS$5,909
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2015CMS$9,440
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2016CMS$10,788
Amneal Pharmaceuticals, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2016CMS$12,367
Amneal Pharmaceuticals, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2019CMS$12,968
Wockhardt USAWockhardt LimitedMedicare Coverage Gap Discount Program violation2020CMS$111,824
Alnylam Pharmaceuticals, Inc.Alnylam PharmaceuticalsMedicare Coverage Gap Discount Program violation2023CMS$31,959
CAMBRIDGE MAJOR LABORATORIES INCAlcamimotor vehicle safety violation2006FMCSA$18,560
EMD CHEMICALS INCORPORATEDMerck KGaA (EMD)motor vehicle safety violation2006FMCSA$7,614
CAMBRIDGE MAJOR LABORATORIES INCAlcamimotor vehicle safety violation2005FMCSA$15,820
EMD CHEMICALS INCORPORATEDMerck KGaA (EMD)motor vehicle safety violation2004FMCSA$13,170
Cody Laboratories IncLannett Co.motor vehicle safety violation2018FMCSA$8,510
Mallinckrodt, Inc.Mallinckrodtnuclear safety violation2000NRC$125,000
Endo Health Solutions Inc.Endo Internationaloff-label or unapproved promotion of medical products2014FDA$192,700,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013FDA$2,200,000,000
Wyeth Pharmaceuticals Inc.Pfizeroff-label or unapproved promotion of medical products2013FDA$490,900,000
Par Pharmaceutical Companies Inc.Endo Internationaloff-label or unapproved promotion of medical products2013FDA$45,000,000
GlaxoSmithKline LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2012FDA$3,000,000,000
Abbott Laboratories Inc.AbbVieoff-label or unapproved promotion of medical products2012FDA$1,500,000,000
Cypress Pharmaceutical Inc.Currax Pharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$2,800,000
Merck, Sharp & DohmeMerckoff-label or unapproved promotion of medical products2011FDA$950,000,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2011FDA$14,500,000
Scios Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2011FDA$85,000,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011FDA$25,000,000
UCB Inc.UCBoff-label or unapproved promotion of medical products2011FDA$34,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.